{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T10:53:24Z","timestamp":1771930404917,"version":"3.50.1"},"reference-count":113,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T00:00:00Z","timestamp":1733788800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.bbcan.2024.189235","type":"journal-article","created":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T07:59:05Z","timestamp":1733471945000},"page":"189235","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Organoids in lung cancer brain metastasis: Foundational research, clinical translation, and prospective outlooks"],"prefix":"10.1016","volume":"1880","author":[{"given":"Mei","family":"Zheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jialin","family":"Qu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongxi","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ligang","family":"Xing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbcan.2024.189235_bb0005","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1093\/annonc\/mdx481","article-title":"Emerging treatment paradigms for brain metastasis in non-small-cell lung cancer: an overview of the current landscape and challenges ahead","volume":"28","author":"Ulahannan","year":"2017","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.bbcan.2024.189235_bb0010","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1002\/1097-0142(197911)44:5<1885::AID-CNCR2820440550>3.0.CO;2-F","article-title":"CNS metastases in small cell bronchogenic carcinoma: increasing frequency and changing pattern with lengthening survival","volume":"44","author":"Nugent","year":"1979","journal-title":"Cancer"},{"key":"10.1016\/j.bbcan.2024.189235_bb0015","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0140-6736(21)00312-3","article-title":"Lung cancer","volume":"398","author":"Thai","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.bbcan.2024.189235_bb0020","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1023\/A:1024251721818","article-title":"Safety of multiple stereotactic radiosurgery treatments for multiple brain lesions","volume":"63","author":"Hillard","year":"2003","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.bbcan.2024.189235_bb0025","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3340\/jkns.2009.45.5.275","article-title":"Radiosurgery for recurrent brain metastases after whole-brain radiotherapy\u202f: factors affecting radiation-induced neurological dysfunction","volume":"45","author":"Gwak","year":"2009","journal-title":"J. Korean Neurosurg. Soc."},{"key":"10.1016\/j.bbcan.2024.189235_bb0030","doi-asserted-by":"crossref","first-page":"38789","DOI":"10.18632\/oncotarget.5887","article-title":"In vitro modeling to determine mutation specificity of EGFR tyrosine kinase inhibitors against clinically relevant EGFR mutants in non-small-cell lung cancer","volume":"6","author":"Hirano","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbcan.2024.189235_bb0035","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.21037\/tlcr-20-154","article-title":"Patient-derived cell line, xenograft and organoid models in lung cancer therapy","volume":"9","author":"Huo","year":"2020","journal-title":"Transl. Lung Cancer Res."},{"key":"10.1016\/j.bbcan.2024.189235_bb0040","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1038\/s41598-021-81832-1","article-title":"Development and characterization of patient-derived xenografts from non-small cell lung cancer brain metastases","volume":"11","author":"Baschnagel","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbcan.2024.189235_bb0045","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/nrclinonc.2012.61","article-title":"Patient-derived tumour xenografts as models for oncology drug development","volume":"9","author":"Tentler","year":"2012","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2024.189235_bb0050","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s13045-017-0470-7","article-title":"Current status and perspectives of patient-derived xenograft models in cancer research","volume":"10","author":"Lai","year":"2017","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bbcan.2024.189235_bb0055","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1158\/2159-8290.CD-17-0935","article-title":"Genomic and functional Fidelity of small cell lung Cancer patient-derived xenografts","volume":"8","author":"Drapkin","year":"2018","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bbcan.2024.189235_bb0060","doi-asserted-by":"crossref","first-page":"3287","DOI":"10.1158\/1078-0432.CCR-19-2777","article-title":"Repotrectinib exhibits potent antitumor activity in treatment-Na\u00efve and solvent-front-mutant ROS1-rearranged non-small cell lung Cancer","volume":"26","author":"Yun","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2024.189235_bb0065","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.517","article-title":"Glutathione peroxidase 4-dependent glutathione high-consumption drives acquired platinum chemoresistance in lung cancer-derived brain metastasis","volume":"11","author":"Liu","year":"2021","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.bbcan.2024.189235_bb0070","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1158\/1078-0432.CCR-19-1871","article-title":"Preclinical comparison of the blood-brain barrier permeability of Osimertinib with other EGFR TKIs","volume":"27","author":"Colclough","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2024.189235_bb0075","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1158\/1078-0432.CCR-22-0383","article-title":"Activity of Adagrasib (MRTX849) in brain metastases: preclinical models and clinical data from patients with KRASG12C-mutant non-small cell lung Cancer","volume":"28","author":"Sabari","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2024.189235_bb0080","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1440-1789.2007.00826.x","article-title":"An experimental model of brain metastasis of lung carcinoma","volume":"28","author":"Zhang","year":"2008","journal-title":"Neuropathology"},{"key":"10.1016\/j.bbcan.2024.189235_bb0085","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1158\/0008-5472.CAN-15-0727","article-title":"Maintaining tumor heterogeneity in patient-derived tumor xenografts","volume":"75","author":"Cassidy","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2024.189235_bb0090","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/j.cell.2016.05.082","article-title":"Modeling development and disease with organoids","volume":"165","author":"Clevers","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2024.189235_bb0095","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/s41568-018-0007-6","article-title":"Organoids in cancer research","volume":"18","author":"Drost","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbcan.2024.189235_bb0100","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature17038","article-title":"Metastatic colonization by circulating tumour cells","volume":"529","author":"Massagu\u00e9","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2024.189235_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2020.116755","article-title":"Metastases to the central nervous system: molecular basis and clinical considerations","volume":"412","author":"Wanleenuwat","year":"2020","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.bbcan.2024.189235_bb0110","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1038\/ncb3011","article-title":"Analysis of tumour- and stroma-supplied proteolytic networks reveals a brain-metastasis-promoting role for cathepsin S","volume":"16","author":"Sevenich","year":"2014","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbcan.2024.189235_bb0115","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.actbio.2019.04.053","article-title":"AKR1B10 (Aldo-keto reductase family 1 B10) promotes brain metastasis of lung cancer cells in a multi-organ microfluidic chip model","volume":"91","author":"Liu","year":"2019","journal-title":"Acta Biomater."},{"key":"10.1016\/j.bbcan.2024.189235_bb0120","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1007\/s00109-015-1357-0","article-title":"The brain metastatic niche","volume":"93","author":"Winkler","year":"2015","journal-title":"J. Mol. Med. (Berl.)"},{"key":"10.1016\/j.bbcan.2024.189235_bb0125","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.bbcan.2016.12.001","article-title":"Brain metastasis: unique challenges and open opportunities","volume":"1867","author":"Lowery","year":"2017","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.bbcan.2024.189235_bb0130","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.3389\/fimmu.2019.01713","article-title":"Microenvironmental regulation of tumor progression and therapeutic response in brain metastasis","volume":"10","author":"Schulz","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2024.189235_bb0135","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.698844","article-title":"The immune microenvironment in brain metastases of non-small cell lung Cancer","volume":"11","author":"Luo","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbcan.2024.189235_bb0140","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1093\/neuonc\/nou128","article-title":"Role of the endothelin axis in astrocyte- and endothelial cell-mediated chemoprotection of cancer cells","volume":"16","author":"Kim","year":"2014","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.bbcan.2024.189235_bb0145","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s10585-010-9354-8","article-title":"Interaction between lung cancer cells and astrocytes via specific inflammatory cytokines in the microenvironment of brain metastasis","volume":"28","author":"Seike","year":"2011","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.bbcan.2024.189235_bb0150","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s00401-010-0774-y","article-title":"CD11c-expressing cells reside in the juxtavascular parenchyma and extend processes into the glia limitans of the mouse nervous system","volume":"121","author":"Prodinger","year":"2011","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbcan.2024.189235_bb0155","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41582-020-0391-x","article-title":"Management of brain metastases according to molecular subtypes","volume":"16","author":"Soffietti","year":"2020","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.bbcan.2024.189235_bb0160","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1200\/JCO.2014.58.3708","article-title":"Overall survival and long-term safety of Nivolumab (anti-programmed death 1 antibody, BMS-936558, ONO-4538) in patients with previously treated advanced non-small-cell lung Cancer","volume":"33","author":"Gettinger","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2024.189235_bb0165","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1470-2045(16)30624-6","article-title":"Nivolumab plus ipilimumab as first-line treatment for advanced non-small-cell lung cancer (CheckMate 012): results of an open-label, phase 1, multicohort study","volume":"18","author":"Hellmann","year":"2017","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bbcan.2024.189235_bb0170","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/nature07935","article-title":"Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche","volume":"459","author":"Sato","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2024.189235_bb0175","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nature12517","article-title":"Cerebral organoids model human brain development and microcephaly","volume":"501","author":"Lancaster","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2024.189235_bb0180","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/JTO.0b013e3182779ccf","article-title":"Spheroid culture of primary lung cancer cells with neuregulin 1\/HER3 pathway activation","volume":"8","author":"Endo","year":"2013","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.bbcan.2024.189235_bb0185","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.chembiol.2017.06.012","article-title":"Tumor organoids as a pre-clinical Cancer model for drug discovery","volume":"24","author":"Weeber","year":"2017","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.bbcan.2024.189235_bb0190","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/s41592-018-0070-7","article-title":"Genetically engineered cerebral organoids model brain tumor formation","volume":"15","author":"Bian","year":"2018","journal-title":"Nat. Methods"},{"key":"10.1016\/j.bbcan.2024.189235_bb0195","doi-asserted-by":"crossref","first-page":"16464","DOI":"10.1096\/fj.202000372R","article-title":"A simple metastatic brain cancer model using human embryonic stem cell-derived cerebral organoids","volume":"34","author":"Choe","year":"2020","journal-title":"FASEB J."},{"key":"10.1016\/j.bbcan.2024.189235_bb0200","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.cell.2015.03.053","article-title":"Prospective derivation of a living organoid biobank of colorectal cancer patients","volume":"161","author":"van de Wetering","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2024.189235_bb0205","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.cell.2014.12.021","article-title":"Organoid models of human and mouse ductal pancreatic cancer","volume":"160","author":"Boj","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2024.189235_bb0210","doi-asserted-by":"crossref","first-page":"677","DOI":"10.32604\/or.2023.029718","article-title":"Mini-organs with big impact: organoids in liver cancer studies","volume":"31","author":"Khawar","year":"2023","journal-title":"Oncol. Res."},{"key":"10.1016\/j.bbcan.2024.189235_bb0215","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.stem.2020.07.022","article-title":"Organoids model transcriptional hallmarks of oncogenic KRAS activation in lung epithelial progenitor cells","volume":"27","author":"Dost","year":"2020","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.bbcan.2024.189235_bb0220","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.cell.2017.11.010","article-title":"A living biobank of breast Cancer organoids captures disease heterogeneity","volume":"172","author":"Sachs","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2024.189235_bb0225","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1158\/0008-5472.CAN-15-2402","article-title":"A three-dimensional organoid culture system derived from human glioblastomas recapitulates the hypoxic gradients and Cancer stem cell heterogeneity of tumors found in vivo","volume":"76","author":"Hubert","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2024.189235_bb0230","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/nrm2236","article-title":"The third dimension bridges the gap between cell culture and live tissue","volume":"8","author":"Pampaloni","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbcan.2024.189235_bb0235","first-page":"3015","article-title":"Deconstructing the third dimension: how 3D culture microenvironments alter cellular cues","volume":"125","author":"Baker","year":"2012","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bbcan.2024.189235_bb0240","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1002\/biot.201300492","article-title":"Three-dimensional models of cancer for pharmacology and cancer cell biology: capturing tumor complexity in vitro\/ex vivo","volume":"9","author":"Hickman","year":"2014","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.bbcan.2024.189235_bb0245","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.apsb.2015.07.005","article-title":"Cancer metastases: challenges and opportunities","volume":"5","author":"Guan","year":"2015","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.bbcan.2024.189235_bb0250","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1016\/j.celrep.2019.02.063","article-title":"Modeling patient-derived glioblastoma with cerebral organoids","volume":"26","author":"Linkous","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbcan.2024.189235_bb0255","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s13045-018-0662-9","article-title":"Organoid technology and applications in cancer research","volume":"11","author":"Xu","year":"2018","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bbcan.2024.189235_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2021.188527","article-title":"Recent advances in organoid development and applications in disease modeling","volume":"1875","author":"Rauth","year":"2021","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.bbcan.2024.189235_bb0265","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1038\/nprot.2014.158","article-title":"Generation of cerebral organoids from human pluripotent stem cells","volume":"9","author":"Lancaster","year":"2014","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.bbcan.2024.189235_bb0270","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.stem.2016.11.017","article-title":"Induction of expansion and folding in human cerebral organoids","volume":"20","author":"Li","year":"2017","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.bbcan.2024.189235_bb0275","first-page":"1","article-title":"A simple method of generating 3D brain organoids using standard laboratory equipment","volume":"1576","author":"Sutcliffe","year":"2019","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.bbcan.2024.189235_bb0280","doi-asserted-by":"crossref","DOI":"10.1242\/dev.166074","article-title":"Brain organoids: advances, applications and challenges","volume":"146","author":"Qian","year":"2019","journal-title":"Development"},{"key":"10.1016\/j.bbcan.2024.189235_bb0285","doi-asserted-by":"crossref","DOI":"10.3390\/cells11061029","article-title":"Protective effect of human-neural-crest-derived nasal turbinate stem cells against amyloid-\u03b2 neurotoxicity through inhibition of Osteopontin in a human cerebral organoid model of Alzheimer\u2019s disease","volume":"11","author":"Lim","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.bbcan.2024.189235_bb0290","doi-asserted-by":"crossref","first-page":"4397","DOI":"10.1158\/1078-0432.CCR-20-5026","article-title":"Modeling clinical responses to targeted therapies by patient-derived organoids of advanced lung adenocarcinoma","volume":"27","author":"Kim","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2024.189235_bb0295","doi-asserted-by":"crossref","first-page":"7408","DOI":"10.1038\/s41467-023-43242-x","article-title":"Genomic profiling and pre-clinical modelling of breast cancer leptomeningeal metastasis reveals acquisition of a lobular-like phenotype","volume":"14","author":"Fitzpatrick","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2024.189235_bb0300","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3389\/fncel.2019.00230","article-title":"A novel Transwell blood brain barrier model using primary human cells","volume":"13","author":"Stone","year":"2019","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.bbcan.2024.189235_bb0305","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.actbio.2020.04.023","article-title":"Ultrasmall gold nanoparticles (2 nm) can penetrate and enter cell nuclei in an in vitro 3D brain spheroid model","volume":"111","author":"Sokolova","year":"2020","journal-title":"Acta Biomater."},{"key":"10.1016\/j.bbcan.2024.189235_bb0310","doi-asserted-by":"crossref","DOI":"10.3390\/cells10082036","article-title":"Human blood vessel organoids penetrate human cerebral organoids and form a vessel-like system","volume":"10","author":"Ahn","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.bbcan.2024.189235_bb0315","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nature14415","article-title":"Sequential cancer mutations in cultured human intestinal stem cells","volume":"521","author":"Drost","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2024.189235_bb0320","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1126\/science.aao3130","article-title":"Use of CRISPR-modified human stem cell organoids to study the origin of mutational signatures in cancer","volume":"358","author":"Drost","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.bbcan.2024.189235_bb0325","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/s41588-019-0399-6","article-title":"Ongoing chromosomal instability and karyotype evolution in human colorectal cancer organoids","volume":"51","author":"Bolhaqueiro","year":"2019","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbcan.2024.189235_bb0330","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/s43018-021-00184-x","article-title":"The metabolic landscape of RAS-driven cancers from biology to therapy","volume":"2","author":"Mukhopadhyay","year":"2021","journal-title":"Nat. Can."},{"key":"10.1016\/j.bbcan.2024.189235_bb0335","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.cmet.2016.01.007","article-title":"Environment impacts the metabolic dependencies of Ras-driven non-small cell lung Cancer","volume":"23","author":"Davidson","year":"2016","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbcan.2024.189235_bb0340","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/s43018-020-0102-y","article-title":"Applications of organoids for Cancer biology and precision medicine","volume":"1","author":"Lo","year":"2020","journal-title":"Nat. Can."},{"key":"10.1016\/j.bbcan.2024.189235_bb0345","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/j.celrep.2018.03.105","article-title":"Glioblastoma Model Using Human Cerebral Organoids","volume":"23","author":"Ogawa","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbcan.2024.189235_bb0350","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1093\/neuonc\/noac118","article-title":"Brain metastases: a Society for Neuro-Oncology (SNO) consensus review on current management and future directions","volume":"24","author":"Aizer","year":"2022","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.bbcan.2024.189235_bb0355","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1200\/JCO.21.02314","article-title":"Treatment for brain metastases: ASCO-SNO-ASTRO guideline","volume":"40","author":"Vogelbaum","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2024.189235_bb0360","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S2213-2600(17)30262-X","article-title":"Icotinib versus whole-BRAIN irradiation in patients with EGFR-mutant non-small-cell lung cancer and multiple BRAIN metastases (BRAIN): a multicentre, phase 3, open-label, parallel, randomised controlled trial","volume":"5","author":"Yang","year":"2017","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.bbcan.2024.189235_bb0365","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2018.78.3118","article-title":"CNS response to Osimertinib versus standard epidermal growth factor receptor tyrosine kinase inhibitors in patients with untreated EGFR-mutated advanced non-small-cell lung Cancer","author":"Reungwetwattana","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2024.189235_bb0370","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.1200\/JCO.2016.68.4639","article-title":"Pooled analysis of CNS response to Alectinib in two studies of pretreated patients with ALK-positive non-small-cell lung Cancer","volume":"34","author":"Gadgeel","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2024.189235_bb0375","article-title":"Brigatinib and Alectinib for ALK rearrangement-positive advanced non-small cell lung Cancer with or without central nervous system metastasis: a systematic review and network Meta-analysis","volume":"12","author":"Ando","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbcan.2024.189235_bb0380","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/S1470-2045(15)00614-2","article-title":"Activity and safety of ceritinib in patients with ALK-rearranged non-small-cell lung cancer (ASCEND-1): updated results from the multicentre, open-label, phase 1 trial","volume":"17","author":"Kim","year":"2016","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bbcan.2024.189235_bb0385","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1158\/1078-0432.CCR-21-2733","article-title":"Tepotinib efficacy and safety in patients with MET exon 14 skipping NSCLC: outcomes in patient subgroups from the VISION study with relevance for clinical practice","volume":"28","author":"Le","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2024.189235_bb0390","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1016\/S1470-2045(19)30655-2","article-title":"Lorlatinib in advanced ROS1-positive non-small-cell lung cancer: a multicentre, open-label, single-arm, phase 1-2 trial","volume":"20","author":"Shaw","year":"2019","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bbcan.2024.189235_bb0395","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/S1470-2045(16)30146-2","article-title":"Dabrafenib plus trametinib in patients with previously treated BRAF(V600E)-mutant metastatic non-small cell lung cancer: an open-label, multicentre phase 2 trial","volume":"17","author":"Planchard","year":"2016","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bbcan.2024.189235_bb0400","doi-asserted-by":"crossref","first-page":"21304","DOI":"10.1038\/s41598-021-00706-8","article-title":"Patient-derived organoids as a platform for modeling a patient\u2019s response to chemoradiotherapy in esophageal cancer","volume":"11","author":"Karakasheva","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbcan.2024.189235_bb0405","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/hep.29526","article-title":"Radiosensitization by inhibiting DNA repair: turning the spotlight on homologous recombination","volume":"67","author":"Venkatesulu","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.bbcan.2024.189235_bb0410","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1158\/1078-0432.CCR-20-3358","article-title":"The challenge of combining chemo- and radiotherapy with checkpoint kinase inhibitors","volume":"27","author":"van Bijsterveldt","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2024.189235_bb0415","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/jnci\/djs472","article-title":"NCI-RTOG translational program strategic guidelines for the early-stage development of radiosensitizers","volume":"105","author":"Lawrence","year":"2013","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.bbcan.2024.189235_bb0420","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.clon.2007.03.010","article-title":"Chemical radiosensitizers for use in radiotherapy","volume":"19","author":"Wardman","year":"2007","journal-title":"Clin. Oncol. (R Coll Radiol)"},{"key":"10.1016\/j.bbcan.2024.189235_bb0425","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/s12885-017-3193-9","article-title":"The allosteric AKT inhibitor MK2206 shows a synergistic interaction with chemotherapy and radiotherapy in glioblastoma spheroid cultures","volume":"17","author":"Narayan","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bbcan.2024.189235_bb0430","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2020.101411","article-title":"Human lung adenocarcinoma-derived organoid models for drug screening","volume":"23","author":"Li","year":"2020","journal-title":"iScience"},{"key":"10.1016\/j.bbcan.2024.189235_bb0435","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109429","article-title":"A pan-cancer organoid platform for precision medicine","volume":"36","author":"Larsen","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbcan.2024.189235_bb0440","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/s41551-020-0565-2","article-title":"High-throughput automated organoid culture via stem-cell aggregation in microcavity arrays","volume":"4","author":"Brandenberg","year":"2020","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.bbcan.2024.189235_bb0445","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nature13385","volume":"511","author":"Comprehensive molecular profiling of lung adenocarcinoma","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2024.189235_bb0450","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/s41568-019-0179-8","article-title":"Co-occurring genomic alterations in non-small-cell lung cancer biology and therapy","volume":"19","author":"Skoulidis","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbcan.2024.189235_bb0455","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aay2574","article-title":"Patient-derived organoids can predict response to chemotherapy in metastatic colorectal cancer patients","volume":"11","author":"Ooft","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bbcan.2024.189235_bb0460","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.stem.2019.10.010","article-title":"Patient-derived organoids predict Chemoradiation responses of locally advanced rectal Cancer","volume":"26","author":"Yao","year":"2020","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.bbcan.2024.189235_bb0465","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1126\/science.aao2774","article-title":"Patient-derived organoids model treatment response of metastatic gastrointestinal cancers","volume":"359","author":"Vlachogiannis","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.bbcan.2024.189235_bb0470","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.121490","article-title":"Human primary liver cancer organoids reveal intratumor and interpatient drug response heterogeneity","volume":"4","author":"Li","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.bbcan.2024.189235_bb0475","doi-asserted-by":"crossref","first-page":"1109274","DOI":"10.3389\/fonc.2023.1109274","article-title":"Organoid drug screening report for a non-small cell lung cancer patient with EGFR gene mutation negativity: a case report and review of the literature","volume":"13","author":"Pan","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbcan.2024.189235_bb0480","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.2147\/IJWH.S405010","article-title":"Effective treatment for recurrent ovarian Cancer guided by drug sensitivity from ascites-derived organoid: a case report","volume":"15","author":"Chen","year":"2023","journal-title":"Int. J. Women\u2019s Health"},{"key":"10.1016\/j.bbcan.2024.189235_bb0485","doi-asserted-by":"crossref","first-page":"463","DOI":"10.3171\/jns.1990.72.3.0463","article-title":"Multicellular tumor spheroids from human gliomas maintained in organ culture","volume":"72","author":"Bjerkvig","year":"1990","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.bbcan.2024.189235_bb0490","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41577-019-0248-y","article-title":"Organoids in immunological research","volume":"20","author":"Bar-Ephraim","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbcan.2024.189235_bb0495","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1158\/2159-8290.CD-20-0057","article-title":"Tumor microenvironment is critical for the maintenance of cellular states found in primary glioblastomas","volume":"10","author":"Pine","year":"2020","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bbcan.2024.189235_bb0500","doi-asserted-by":"crossref","first-page":"66747","DOI":"10.18632\/oncotarget.19965","article-title":"Application of 3D tumoroid systems to define immune and cytotoxic therapeutic responses based on tumoroid and tissue slice culture molecular signatures","volume":"8","author":"Finnberg","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbcan.2024.189235_bb0505","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/s41416-019-0616-1","article-title":"Patient-derived organoids as a potential model to predict response to PD-1\/PD-L1 checkpoint inhibitors","volume":"121","author":"Scognamiglio","year":"2019","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbcan.2024.189235_bb0510","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1039\/C8LC00322J","article-title":"3D microfluidic ex vivo culture of organotypic tumor spheroids to model immune checkpoint blockade","volume":"18","author":"Aref","year":"2018","journal-title":"Lab Chip"},{"key":"10.1016\/j.bbcan.2024.189235_bb0515","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S1470-2045(20)30111-X","article-title":"Pembrolizumab for management of patients with NSCLC and brain metastases: long-term results and biomarker analysis from a non-randomised, open-label, phase 2 trial","volume":"21","author":"Goldberg","year":"2020","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bbcan.2024.189235_bb0520","article-title":"Outcomes with Pembrolizumab monotherapy in patients with programmed death-ligand 1-positive NSCLC with brain metastases: pooled analysis of KEYNOTE-001, 010, 024, and 042","volume":"2","author":"Mansfield","year":"2021","journal-title":"JTO Clin. Res. Rep."},{"key":"10.1016\/j.bbcan.2024.189235_bb0525","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41571-018-0046-7","article-title":"Safety of combining radiotherapy with immune-checkpoint inhibition","volume":"15","author":"Hwang","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2024.189235_bb0530","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-002891","article-title":"Oncogene-specific differences in tumor mutational burden, PD-L1 expression, and outcomes from immunotherapy in non-small cell lung cancer","volume":"9","author":"Negrao","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.bbcan.2024.189235_bb0535","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.canlet.2019.10.027","article-title":"The superior efficacy of anti-PD-1\/PD-L1 immunotherapy in KRAS-mutant non-small cell lung cancer that correlates with an inflammatory phenotype and increased immunogenicity","volume":"470","author":"Liu","year":"2020","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbcan.2024.189235_bb0540","doi-asserted-by":"crossref","first-page":"25840","DOI":"10.1021\/acsami.6b08746","article-title":"Design and construction of a multi-organ microfluidic Chip mimicking the in vivo microenvironment of lung Cancer metastasis","volume":"8","author":"Xu","year":"2016","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.bbcan.2024.189235_bb0545","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/s41419-019-1618-x","article-title":"M2 macrophages promote NSCLC metastasis by upregulating CRYAB","volume":"10","author":"Guo","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbcan.2024.189235_bb0550","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2020.612091","article-title":"Proteomic reveals reasons for acquired drug resistance in lung Cancer derived brain metastasis based on a newly established multi-organ microfluidic Chip model","volume":"8","author":"Xu","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.bbcan.2024.189235_bb0555","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1363139","article-title":"Trial watch: adoptively transferred cells for anticancer immunotherapy","volume":"6","author":"Fournier","year":"2017","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.bbcan.2024.189235_bb0560","doi-asserted-by":"crossref","DOI":"10.3390\/cancers10100356","article-title":"The current status and future prospects of oncolytic viruses in clinical trials against melanoma, glioma, pancreatic, and breast cancers","volume":"10","author":"Eissa","year":"2018","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbcan.2024.189235_bb0565","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1038\/s41467-022-29647-0","article-title":"Targeting brain lesions of non-small cell lung cancer by enhancing CCL2-mediated CAR-T cell migration","volume":"13","author":"Li","year":"2022","journal-title":"Nat. Commun."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X24001665?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X24001665?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T23:15:21Z","timestamp":1737587721000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304419X24001665"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":113,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S0304419X24001665"],"URL":"https:\/\/doi.org\/10.1016\/j.bbcan.2024.189235","relation":{},"ISSN":["0304-419X"],"issn-type":[{"value":"0304-419X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Organoids in lung cancer brain metastasis: Foundational research, clinical translation, and prospective outlooks","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbcan.2024.189235","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"189235"}}